The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1293
August 25, 2008
View Complete Issue         Table of Contents 2019 
Zingo for Local Analgesia in Children
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Zingo for Local Analgesia in Children
August 25, 2008 (Issue: 1293)
The FDA has approved the marketing of a new device for delivering lidocaine to the skin of children undergoing a venipuncture or intravenous (IV) line placement. Zingo (Anesiva) is a powder intradermal injection system.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Zingo for Local Analgesia in Children
Article code: 1293d
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.